Higher post-induction infliximab concentrations are associated with improved clinical outcomes in fistulizing Crohn’s disease: an ACCENT-II post-hoc analysis

OBJECTIVES: There are only limited data regarding the role of therapeutic drug monitoring in fistulizing Crohn’s disease (CD). We investigated the association between both induction and maintenance serum infliximab concentrations and favorable therapeutic outcomes in patients with fistulizing CD. ME...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Gastroenterol
Main Authors: Papamichael, Konstantinos, Casteele, Niels Vande, Jeyarajah, Jenny, Jairath, Vipul, Osterman, Mark T., Cheifetz, Adam S.
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8095681/
https://ncbi.nlm.nih.gov/pubmed/33929379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000001111
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares